Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Response to Nathan et al.
- Vincent Woo, MD, FRCPC and
- for the CDA 2008 Clinical Practice Guidelines Steering Committee*
- From the Endocrinology Section, Department of Internal Medicine, University of Manitoba, Winnipeg, Canada; and the Health Sciences Centre, University of Manitoba, Winnipeg, Canada
- Corresponding author: Vincent Woo, woovc{at}cc.umanitoba.ca
The evidence-based Canadian Diabetes Association (CDA) 2008 clinical practice guidelines for the prevention and treatment of diabetes in Canada (1) differ from the consensus statement by Nathan et al. (2), although both were published virtually at the same time. The consensus statement, which represents the authors’ collective analysis, evaluation, and opinion, is said not to represent official association opinion, yet it is listed as a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. In contrast, the CDA clinical practice guidelines do represent the CDA's official position. The CDA clinical practice guidelines follow the AGREE (Appraisal of Guidelines for Research and Evaluation) instrument (3) and have a standardized evidence-based approach to …
